Sorrento Therpt (NQ: SRNE )

6.775 USD -0.425 (-5.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2021 Add to My Watchlist

Price and Volume

Volume	5,778,491
Open	7.190
Bid (Size)	6.810 (4)
Ask (Size)	6.880 (5)
Prev. Close	7.200
Today's Range	6.760 - 7.210
52wk Range	2.560 - 19.39
Shares Outstanding	286,650,738
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Personalized Stem Cells Announces Enrollment Complete for COVID-19 Clinical Trial Licensed to Sorrento Therapeutics

May 04, 2021

Sorrento Receives FDA Clearance to Proceed With Phase 2 Study for Sti-3031, an Anti-Pd-L1 Antibody, for Advanced Urothelial Carcinoma

April 27, 2021

Performance

YTD	-4.17%	-4.17%
1 Month	-9.79%	-9.79%
3 Month	-58.96%	-58.96%
6 Month	+17.62%	+17.62%
1 Year	+141.96%	+141.96%

More News

The Importance of Alternative Healthcare Options Grows in the Midst of the Pandemic

April 20, 2021

Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate

April 20, 2021

Additional Positive Results in COVID-19 Clinical Trial Using Stem Cells Manufactured by Performance Cell Manufacturing

April 20, 2021

Ocugen Stock Has a Big Pullback Coming, and That Will Be Your Chance

May 07, 2021

Personalized Stem Cells Announces Additional Treatments in COVID-19 Clinical Trial Licensed to Sorrento Therapeutics

April 13, 2021

Sorrento To Start Testing STI-3031 In Patients With Advanced Urothelial Carcinoma

April 27, 2021

Why Sorrento Therapeutics' Stock Is Trading Higher Today

April 27, 2021

Market Briefing For Thursday, May 6

May 06, 2021

Market Briefing For Wednesday, May 5

May 05, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.